We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DKSH:SIXDKSH Holding Ltd Analysis

Data as of 2026-03-15 - not real-time

$61.43

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

DKSH Holding AG is trading at $61.43, modestly above its DCF‑derived fair value of $54.7, yet its trailing P/E of 15.4 is well below the industry average of 29, indicating a relative valuation discount. Recent earnings showed a 2.9% constant‑FX revenue uptick and a 6.7% YoY increase in core EBIT with margin expansion to 3.2%, driving a 4% share price rally on the results. The stock offers an attractive 4.6% dividend yield with a 75% payout ratio, supported by solid operating cash flow and a manageable debt‑to‑equity of 41%. Technicals are neutral: the 20‑day SMA sits at $70, the price is below this support, the MACD histogram is bearish, and the 30‑day volatility is effectively zero, reflecting a very low‑risk price environment. With a near‑zero beta (‑0.02) and stable volume, the equity behaves almost like a cash‑like instrument, though thin trading raises liquidity concerns. Overall, the combination of strong cash generation, dividend appeal, and recent earnings momentum suggests upside potential, while valuation and liquidity constraints temper expectations.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below 20‑day SMA indicating near‑term support pressure
  • Bearish MACD histogram suggesting limited upside
  • Recent earnings beat and dividend yield provide cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Momentum from H2 EBIT growth and margin expansion
  • Attractive dividend yield with sustainable payout
  • Valuation discount relative to industry peers

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Stable cash flows and low beta reducing market risk
  • Diversified service platform across healthcare and consumer goods
  • Consistent dividend policy supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth-1.80%
Profit Margin1.83%
P/E Ratio15.4
ROE11.40%
ROA3.68%
Debt/Equity41.35
P/B Ratio1.8
Op. Cash Flow$320.1M
Free Cash Flow$285.4M
Industry P/E29.1

Technical Analysis

TrendNeutral
RSI50.3
Support$70.01
Resistance$70.01
MA 20$70.01
MA 50$70.16
MA 200$67.91
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair Value$54.69
GradeFair
TypeGrowth
Dividend Yield4.60%

Risk Assessment

Beta-0.02
0
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.